Hongluan Mao
No.107 Wenhua West Road
Jinan, 250012, China
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids.
Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Published: December 03, 2024
Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients.
Journal: Journal of inflammation research
Published: December 14, 2022
The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit.
Journal: Frontiers in genetics
Published: November 05, 2022
The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer.
Journal: Journal of translational medicine
Published: February 16, 2022
Low Density Lipoprotein Receptor (LDLR) and 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase (HMGCR) Expression are Associated with Platinum-Resistance and Prognosis in Ovarian Carcinoma Patients.
Journal: Cancer management and research
Published: September 23, 2021
Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer via Integrated Bioinformatics Analysis.
Journal: Cancer management and research
Published: August 29, 2021
Corrigendum: Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway.
Journal: Frontiers in oncology
Published: July 16, 2021
GABPA Expression in Endometrial Carcinoma: A Prognostic Marker.
Journal: Disease markers
Published: February 09, 2021
Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway.
Journal: Frontiers in oncology
Published: December 15, 2020
Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo.
Journal: OncoTargets and therapy
Published: January 27, 2020
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer.
Journal: OncoTargets and therapy
Published: June 21, 2019
ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Journal: Journal of translational medicine
Published: May 14, 2019
Last Updated: 09/26/2026